Effects of Supplementation with Curcuminoids on Dyslipidemia in Obese Patients: A Randomized Crossover Trial
- 21 May 2012
- journal article
- research article
- Published by Wiley in Phytotherapy Research
- Vol. 27 (3), 374-379
- https://doi.org/10.1002/ptr.4715
Abstract
Dyslipidemia is a leading risk factor for cardiovascular disease and is also a common feature of obesity. Curcumin is a bioactive phytochemical with well‐known antioxidant, anti‐inflammatory, and cardioprotective properties. The present study investigated the hypolipidemic activity of curcumin in obese individuals. Participants (n = 30) were treated with curcuminoids (1 g/day), or placebo in a randomized, double‐blind, placebo‐controlled, crossover trial. Serum concentrations of total cholesterol, triglycerides, low‐density lipoprotein cholesterol and high‐density lipoprotein cholesterol, together with anthropometric parameters and high‐sensitivity C‐reactive protein were measured before and after each treatment period. Anthropometric parameters including weight, BMI, waist circumference, hip circumference, arm circumference, and body fat remained statistically unchanged by the end of trial (p > 0.05). As for the lipid profile parameters, serum triglycerides were significantly reduced following curcumin supplementation (p = 0.009). However, curcuminoids were not found to affect serum levels of total cholesterol, low‐density lipoprotein cholesterol, high‐density lipoprotein cholesterol, and high‐sensitivity C‐reactive protein (p > 0.05). In summary, the findings of the present study indicated that curcuminoid supplementation (1 g/day for 30 days) leads to a significant reduction in serum triglycerides concentrations but do not have a significant influence on other lipid profile parameters as well as body mass index and body fat. Copyright © 2012 John Wiley & Sons, Ltd.Keywords
This publication has 24 references indexed in Scilit:
- Anthropometric Indices of Obesity and the Prediction of Cardiovascular Risk Factors in an Iranian PopulationThe Scientific World Journal, 2009
- Beneficial effects of curcumin on hyperlipidemia and insulin resistance in high-fat–fed hamstersMetabolism, 2008
- Curcumin effects on blood lipid profile in a 6-month human studyPharmacological Research, 2007
- Curcumin as “Curecumin”: From kitchen to clinicBiochemical Pharmacology, 2007
- Body mass index and quality of well-being in a community of older adultsAmerican Journal of Preventive Medicine, 2004
- A central role for JNK in obesity and insulin resistanceNature, 2002
- Inhibition of the c-Jun N-terminal kinase (JNK) signaling pathway by curcuminOncogene, 1998
- American Heart Association Call to Action: Obesity as a Major Risk Factor for Coronary Heart DiseaseCirculation, 1998
- Obesity and Heart DiseaseCirculation, 1997
- Hypolipidemic action of curcumin, the active principle of turmeric (Curcuma longa) in streptozotocin induced diabetic ratsMolecular and Cellular Biochemistry, 1997